IP2IPO

IP2IPO Group has announced that Professor Graham Richards, non-executive director, is to become non-executive chairman of the company with immediate effect. Dr Bruce Smith, who steps down as non-executive chairman for family reasons, will remain a non-executive Director. Professor Richards became a director of IP2IPO in 2001 and is one of the leading chemists in the UK, with over 350 publications to his name. He has served as chairman of the department of chemistry at Oxford University since 1997. In this role, he has overseen the flourishing partnership between IP2IPO and the chemistry department, which led last year to the opening of Oxford's new state of the art Chemistry Research Laboratory by HM The Queen. Throughout his career, Professor Richards has been involved in the commercialization of technology. In 1989 he co-founded Oxford Molecular Ltd, which later floated on the London Stock Exchange as Oxford Molecular Group plc. He is a director of Isis Innovation Limited, the University of Oxford's technology transfer company and was involved for several years with The Wellcome Trust in a similar capacity. In 2001 he founded Inhibox Limited, a spinout company from the chemistry department in which IP2IPO has an interest.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland